Multi-catheter cryotherapy for the treatment of resistant accessory pathways
- PMID: 37977548
- PMCID: PMC10927982
- DOI: 10.1016/j.ipej.2023.11.002
Multi-catheter cryotherapy for the treatment of resistant accessory pathways
Abstract
Objective: To investigate the utility of simultaneous multi-catheter cryotherapy for the treatment of APs that were previously resistant to standard radiofrequency (RF) catheter ablation.
Background: Catheter ablation is established in the treatment of accessory pathways (AP), with high rates of permanent procedural success with a single attempt. However, there are still instances of acute procedural failure and AP recurrences with standard RF and cryotherapy methods.
Methods: Seven consecutive cases of pre-excitation syndromes with prior failed RF catheter ablation had the novel treatment. Cryotherapy was delivered using two 8 mm tip focal cryoablation catheters (Freezor® Max, Medtronic, Minneapolis, Minnesota, USA).
Results: Accessory pathway localisation was septal in 5 cases, left posterolateral in 1, right lateral in 1. In all cases, ablation of the AP was acutely successful with no procedural complications. Median procedure and fluoroscopy durations were 199 and 35 min, sequentially. Median Procedure duration fell significantly in the second half of series (174 min) compared to the first half (233 min, P = 0.05). One patient had evidence of a recurring AP conduction with pre-excitation at 5-week follow up. After a median follow up of 66.8+-6.5 months, 6 out of 7 patients remained asymptomatic and free of pre-excitation.
Conclusion: Simultaneous multi-catheter cryotherapy is feasible, safe and can provide definitive cure of accessory pathways that were previously resistant to standard radiofrequency ablation. Further study is required in the assessment of this novel form of advanced cryotherapy to treat complex and resistant arrhythmias.
Keywords: Accessory pathway; Catheter ablation; Cryoablation; Pre-excitation; Wolff Parkinson white syndrome.
Copyright © 2023 Indian Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest Dr Gallagher has received research funding from Attune medical and has acted as a consultant and paid speaker for Biosense Webster. No other author has any conflict of interest.
Figures
References
-
- Scheinman M., Calkins H., Gillette P., Klein R., Lerman B.B., Morady F., et al. NASPE policy statement on catheter ablation: personnel, policy, procedures, and therapeutic recommendations. Pacing Clin Electrophysiol. 2003;26:789–799. - PubMed
-
- Calkins H., Yong P., Miller J.M., Olshansky B., Carlson M., Saul J.P., et al. Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group. Circulation. 1999;99:262–270. - PubMed
-
- Jackman W.M., Wang X.Z., Friday K.J., Roman C.A., Moulton K.P., Beckman K.J., et al. Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. N Engl J Med. 1991;324:1605–1611. - PubMed
-
- Dagres N., Clague J.R., Breithardt G., Borggrefe M. Significant gender-related differences in radiofrequency catheter ablation therapy. J Am Coll Cardiol. 2003;42:1103–1107. - PubMed
-
- Kuck K.H., Schlüter M., Geiger M., Siebels J., Duckeck W. Radiofrequency current catheter ablation of accessory atrioventricular pathways. Lancet. 1991;337(8757):1557–1561. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous